跳至主要内容
临床试验/JPRN-UMIN000044853
JPRN-UMIN000044853招募中未知

Effects of Kampo medicine Hochuekkito on fatigue and health-related quality of life in hemodialysis patients with chronic kidney disease: a pilot study - Effects of Kampo medicine Hochuekkito on fatigue and health-related quality of life in hemodialysis patients with chronic kidney disease: a pilot study

Fukushima Medical University School of Medicine0 个研究点目标入组 60 人开始时间: 2021年7月13日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Pregnant or possibly pregnant 2. A history of allergies to hochuekkito 3. Severe hypertension (>= 180/110 mmHg) 4. Onset of cardiovascular disease within 1 month 5. Severe complications including blood disorders, active malignancies, infectious diseases, thyroid disorders, and depression 6. Using steroids, immunosuppressants (e.g. cyclosporine), and glycyrrhizin 7. Using other Kampo medicines 8. Participating in another clinical trial 9. Participants who are judged to be inappropriate

研究者

发起方
Fukushima Medical University School of Medicine

相似试验